Dr. Stefan Koch
Stefan's practice is focused on mergers and acquisitions and private equity deals, as well as joint ventures and capital market transactions.
Drawing on his broad domestic and international experience, Stefan helps clients to navigate complex cross-border transactions, including both public and privately negotiated takeovers.
International both in outlook and approach, Stefan has played a leading role in a number of the Firm's legal teams, seamlessly coordinating advice across multiple offices and territories.
Representing corporate clients, investors and private equity firms, Stefan also offers strategic advice on a range of general corporate law issues, as well as technically complicated capital market, stock exchange and other regulatory matters.
Dual-qualified in New York and Germany, Stefan's international background includes 15 years working in the United States, in New York, and in Germany.
Nordic Capital, 2014-2018
Advised Nordic Capital on its 2018 acquisition of the Prospitalia Group, its 2018 acquisition of the Ober Scharrer Group, its 2017 acquisition of Alloheim, its 2015 acquisition of the Sunrise Medical group and on the 2014 acquisition of GHD GesundHeits GmbH Deutschland from IK InvestmentPartners.
Ardian (formerly Axa Private Equity), 2006-2019*
Advised Ardian on the 2019 acquisition of German Saal Digital, the 2016 acquisition of German Schwind eye-tech solutions GmbH as well as the previous acquisition of the railway sleepers business of Pfleiderer AG; the acquisition of CABB, a specialty chemicals company; the disposal of Alukon, a manufacture of roller shutters; and the disposal of Gealan, a manufacturer of PVC window profiles.
Duke Street, 2016 – 2018
Advised Duke Street on its 2018 acquisition of A-Rosa river cruises and its 2016 acquisition of Medi-Globe.
IK Investment Partners, 2019
Advised IK Investment Partners on its 2019 acquisition of mdt as well as previous transactions.
Battery Ventures, 2015 – 2019
Advised Battery Ventures on its 2019 acquisition of abas Software AG through its portfolio company Forterro, the 2017 disposition of Worldhotels AG and its 2015 US$154 million sale of the German Trust International Group to NASDAQ-listed Sabre Corporation.
ACP Allianz Capital Partners and others, 2015
Advised an international syndicate consisting of Allianz Capital Partners, Borealis Infrastructure Management Inc., Infinity Investments SA and MEAG, the asset management arm of Münchener Rück, on its 2015 acquisition of Autobahn Tank & Rast GmbH, the German autobahn services company.
Advised Grünenthal on its US$235 million license agreement with AstraZeneca for Zurampic.
Groupe Legris Industries, 2016
Advised Groupe Legris Industries on its 2016 acquisition of Schiederwerk.
Super Group Limited, 2015
Advised Super Group Limited on its 2015 €153.5 million acquisition of the IN tIME group from funds advised by Equistone Partners Europe.
Advised Halder on the 2015 acquisition of PRAE-TURBO GmbH & Co. KG through a management buy-out.
Merck KGaA, 2006 – 2015*
Advised Merck KGaA on the 2015 agreement by its Life Science business, Merck Millipore, to acquire the worldwide rights to an innovative protein detection technology from Singulex, the 2015 disposition of its drug discovery and developments solutions business to Eurofins SA, as well as previously on the US$7.2 billion acquisition of Millipore Corporation and the €4.9 billion disposal of its worldwide generics business to Mylan Inc.
*Includes matters worked on prior to joining White & Case
"Closing Documents and common ancillary M&A Agreements in English Language with German Annotations (Closing Dokumente und typische Nebenvereinbarungen in englischer Sprache mit Anmerkungen in deutscher Sprache)". M&A Agreements in Germany. Ed. M. Jaletzke and W. Henle. Munich, Pages 221-247 and 261 -265, 2011
Co-author, "The International Comparative Legal Guide to M&A". Global Legal Group, London, 2010, 2009 and 2008 (with M. Horbach)
Co-author, "Merger Control Regulations' Claim to the Absolute Truth? (Absolutheitsanspruch in der Fusionskontrolle?)", Wirtschaft und Wettbewerb, Issue 11, Page 1127, 2009 (with H. Henschen)
Co-author, "Influence by the Majority Shareholder after a Public Takeover (Einflussnahme nach einer öffentlichen Übernahme)", Going Public Magazin, Pages 81-82, May 2009 (with M. Horbach)
Leading Individual, JUVE 2019/2020
(Private Equity & Venture Capital)
Highly Recommended Lawyer, Germany's Best Lawyers/Handelsblatt 2019
(Private Equity Law)
Highly regarded, IFLR 2019
Ranked individual, Chambers Europe 2019